Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 622 entries
Sorted by: Best Match Show Resources per page
Developing lithium chemistry of 1,2-dihydropyridines: from kinetic intermediates to isolable characterized compounds.

Chemistry (Weinheim an der Bergstrasse, Germany)

Armstrong DR, Harris CM, Kennedy AR, Liggat JJ, McLellan R, Mulvey RE, Urquhart MD, Robertson SD.
PMID: 26333094
Chemistry. 2015 Oct 05;21(41):14410-20. doi: 10.1002/chem.201501880. Epub 2015 Aug 31.

Generally considered kinetic intermediates in addition reactions of alkyllithiums to pyridine, 1-lithio-2-alkyl-1,2-dihydropyridines have been rarely isolated or characterized. This study develops their "isolated" chemistry. By a unique stoichiometric (that is, 1:1, alkyllithium/pyridine ratios) synthetic approach using tridentate donors we...

Cite
Armstrong DR, Harris CM, Kennedy AR, et al. Developing lithium chemistry of 1,2-dihydropyridines: from kinetic intermediates to isolable characterized compounds. Chemistry. 2015;21(41):14410-20doi: 10.1002/chem.201501880.
Armstrong, D. R., Harris, C. M., Kennedy, A. R., Liggat, J. J., McLellan, R., Mulvey, R. E., Urquhart, M. D., & Robertson, S. D. (2015). Developing lithium chemistry of 1,2-dihydropyridines: from kinetic intermediates to isolable characterized compounds. Chemistry (Weinheim an der Bergstrasse, Germany), 21(41), 14410-20. https://doi.org/10.1002/chem.201501880
Armstrong, David R, et al. "Developing lithium chemistry of 1,2-dihydropyridines: from kinetic intermediates to isolable characterized compounds." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 21,41 (2015): 14410-20. doi: https://doi.org/10.1002/chem.201501880
Armstrong DR, Harris CM, Kennedy AR, Liggat JJ, McLellan R, Mulvey RE, Urquhart MD, Robertson SD. Developing lithium chemistry of 1,2-dihydropyridines: from kinetic intermediates to isolable characterized compounds. Chemistry. 2015 Oct 05;21(41):14410-20. doi: 10.1002/chem.201501880. Epub 2015 Aug 31. PMID: 26333094.
Copy Download .nbib Format: NLM
Vibrational spectroscopic mapping and imaging of tissues and cells.

Biophysical reviews

Carter EA, Tam KK, Armstrong RS, Lay PA.
PMID: 28509988
Biophys Rev. 2009 Jul;1(2):95-103. doi: 10.1007/s12551-009-0012-9. Epub 2009 Jun 23.

Vibrational spectroscopic mapping (point-by-point measurement) and imaging of biological samples (cells and tissues) covering Fourier-transform infrared (FTIR) and Raman spectroscopies has opened up many exciting new avenues to explore biochemical architecture and processes within healthy and diseased cells and...

Cite
Carter EA, Tam KK, Armstrong RS, et al. Vibrational spectroscopic mapping and imaging of tissues and cells. Biophys Rev. 2009;1(2):95-103doi: 10.1007/s12551-009-0012-9.
Carter, E. A., Tam, K. K., Armstrong, R. S., & Lay, P. A. (2009). Vibrational spectroscopic mapping and imaging of tissues and cells. Biophysical reviews, 1(2), 95-103. https://doi.org/10.1007/s12551-009-0012-9
Carter, Elizabeth A, et al. "Vibrational spectroscopic mapping and imaging of tissues and cells." Biophysical reviews vol. 1,2 (2009): 95-103. doi: https://doi.org/10.1007/s12551-009-0012-9
Carter EA, Tam KK, Armstrong RS, Lay PA. Vibrational spectroscopic mapping and imaging of tissues and cells. Biophys Rev. 2009 Jul;1(2):95-103. doi: 10.1007/s12551-009-0012-9. Epub 2009 Jun 23. PMID: 28509988; PMCID: PMC5418372.
Copy Download .nbib Format: NLM
IgA nephropathy in identical twins: an excellent donor and recipient outcome 11 years after transplantation.

Clinical kidney journal

Irvine J, Cross N, Lynn K, Robson R, Searle M, Morton J, Armstrong S, Roake J.
PMID: 26069772
Clin Kidney J. 2012 Jun;5(3):232-3. doi: 10.1093/ckj/sfs022. Epub 2012 Mar 26.

We present a case of IgA nephropathy (IgAN) in monozygotic twins with excellent donor and recipient outcome 11 years after transplantation. The recipient developed IgAN at 26 years and progressed to end-stage renal failure 10 years later. His identical...

Cite
Irvine J, Cross N, Lynn K, et al. IgA nephropathy in identical twins: an excellent donor and recipient outcome 11 years after transplantation. Clin Kidney J. 2012;5(3):232-3doi: 10.1093/ckj/sfs022.
Irvine, J., Cross, N., Lynn, K., Robson, R., Searle, M., Morton, J., Armstrong, S., & Roake, J. (2012). IgA nephropathy in identical twins: an excellent donor and recipient outcome 11 years after transplantation. Clinical kidney journal, 5(3), 232-3. https://doi.org/10.1093/ckj/sfs022
Irvine, John, et al. "IgA nephropathy in identical twins: an excellent donor and recipient outcome 11 years after transplantation." Clinical kidney journal vol. 5,3 (2012): 232-3. doi: https://doi.org/10.1093/ckj/sfs022
Irvine J, Cross N, Lynn K, Robson R, Searle M, Morton J, Armstrong S, Roake J. IgA nephropathy in identical twins: an excellent donor and recipient outcome 11 years after transplantation. Clin Kidney J. 2012 Jun;5(3):232-3. doi: 10.1093/ckj/sfs022. Epub 2012 Mar 26. PMID: 26069772; PMCID: PMC4400500.
Copy Download .nbib Format: NLM
Assessing Assessment: Does Health Technology Assessment Do Its Job of Controlling Costs Without Compromising Quality?.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Armstrong S, Garfield S.
PMID: 27201065
Value Health. 2014 Nov;17(7):A420. doi: 10.1016/j.jval.2014.08.1027. Epub 2014 Oct 26.

No abstract available.

Cite
Armstrong S, Garfield S. Assessing Assessment: Does Health Technology Assessment Do Its Job of Controlling Costs Without Compromising Quality?. Value Health. 2014;17(7):A420doi: 10.1016/j.jval.2014.08.1027.
Armstrong, S., & Garfield, S. (2014). Assessing Assessment: Does Health Technology Assessment Do Its Job of Controlling Costs Without Compromising Quality?. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A420. https://doi.org/10.1016/j.jval.2014.08.1027
Armstrong, S, and Garfield, S. "Assessing Assessment: Does Health Technology Assessment Do Its Job of Controlling Costs Without Compromising Quality?." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A420. doi: https://doi.org/10.1016/j.jval.2014.08.1027
Armstrong S, Garfield S. Assessing Assessment: Does Health Technology Assessment Do Its Job of Controlling Costs Without Compromising Quality?. Value Health. 2014 Nov;17(7):A420. doi: 10.1016/j.jval.2014.08.1027. Epub 2014 Oct 26. PMID: 27201065.
Copy Download .nbib Format: NLM
Orthosis reduces breast pain and mechanical forces through natural and augmented breast tissue in women lying prone.

Chiropractic & manual therapies

Ried K, Armstrong S, Sali A, McLaughlin P.
PMID: 24410925
Chiropr Man Therap. 2014 Jan 13;22(1):2. doi: 10.1186/2045-709X-22-2.

BACKGROUND: Breast implant displacement or rupture can cause aesthetic problems and serious medical complications. Activities with prone positioning and loading of the anterior chest wall, such as massage, chiropractic or osteopathic therapies may increase the risk of implant failure...

Cite
Ried K, Armstrong S, Sali A, et al. Orthosis reduces breast pain and mechanical forces through natural and augmented breast tissue in women lying prone. Chiropr Man Therap. 2014;22(1):2doi: 10.1186/2045-709X-22-2.
Ried, K., Armstrong, S., Sali, A., & McLaughlin, P. (2014). Orthosis reduces breast pain and mechanical forces through natural and augmented breast tissue in women lying prone. Chiropractic & manual therapies, 22(1), 2. https://doi.org/10.1186/2045-709X-22-2
Ried, Karin, et al. "Orthosis reduces breast pain and mechanical forces through natural and augmented breast tissue in women lying prone." Chiropractic & manual therapies vol. 22,1 (2014): 2. doi: https://doi.org/10.1186/2045-709X-22-2
Ried K, Armstrong S, Sali A, McLaughlin P. Orthosis reduces breast pain and mechanical forces through natural and augmented breast tissue in women lying prone. Chiropr Man Therap. 2014 Jan 13;22(1):2. doi: 10.1186/2045-709X-22-2. PMID: 24410925; PMCID: PMC3896682.
Copy Download .nbib Format: NLM
The efficacy of winter cover crops to stabilize soil inorganic nitrogen after fall-applied anhydrous ammonia.

Journal of environmental quality

Lacey C, Armstrong S.
PMID: 26023963
J Environ Qual. 2015 Mar;44(2):442-8. doi: 10.2134/jeq2013.12.0529.

There is a dearth of knowledge on the ability of cover crops to increase the effectiveness of fall-applied nitrogen (N). The objective of this study was to investigate the efficacy of two cover crop species to stabilize inorganic soil...

Cite
Lacey C, Armstrong S. The efficacy of winter cover crops to stabilize soil inorganic nitrogen after fall-applied anhydrous ammonia. J Environ Qual. 2015;44(2):442-8doi: 10.2134/jeq2013.12.0529.
Lacey, C., & Armstrong, S. (2015). The efficacy of winter cover crops to stabilize soil inorganic nitrogen after fall-applied anhydrous ammonia. Journal of environmental quality, 44(2), 442-8. https://doi.org/10.2134/jeq2013.12.0529
Lacey, Corey, and Armstrong, Shalamar. "The efficacy of winter cover crops to stabilize soil inorganic nitrogen after fall-applied anhydrous ammonia." Journal of environmental quality vol. 44,2 (2015): 442-8. doi: https://doi.org/10.2134/jeq2013.12.0529
Lacey C, Armstrong S. The efficacy of winter cover crops to stabilize soil inorganic nitrogen after fall-applied anhydrous ammonia. J Environ Qual. 2015 Mar;44(2):442-8. doi: 10.2134/jeq2013.12.0529. PMID: 26023963.
Copy Download .nbib Format: NLM
Person-first language in pediatric obesity research.

Pediatric obesity

Armstrong SC, Puhl R, Skinner AC, Kratka A.
PMID: 28299909
Pediatr Obes. 2018 Feb;13(2):130. doi: 10.1111/ijpo.12211. Epub 2017 Mar 15.

No abstract available.

Cite
Armstrong SC, Puhl R, Skinner AC, et al. Person-first language in pediatric obesity research. Pediatr Obes. 2017;13(2):130doi: 10.1111/ijpo.12211.
Armstrong, S. C., Puhl, R., Skinner, A. C., & Kratka, A. (2018). Person-first language in pediatric obesity research. Pediatric obesity, 13(2), 130. https://doi.org/10.1111/ijpo.12211
Armstrong, S C, et al. "Person-first language in pediatric obesity research." Pediatric obesity vol. 13,2 (2018): 130. doi: https://doi.org/10.1111/ijpo.12211
Armstrong SC, Puhl R, Skinner AC, Kratka A. Person-first language in pediatric obesity research. Pediatr Obes. 2018 Feb;13(2):130. doi: 10.1111/ijpo.12211. Epub 2017 Mar 15. PMID: 28299909.
Copy Download .nbib Format: NLM
Changes in frequencies of variegated leaves in NMU treated tobacco : Evidence for a differential response to NMU.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik

Davidson D, Pertens E, Armstrong SW.
PMID: 24241303
Theor Appl Genet. 1987 Apr;73(6):915-9. doi: 10.1007/BF00289398.

Seeds of Nicotiana tabacum were allowed to imbibe water for 1 h and were then treated with 5-20 mM N-nitroso-N-methylurea (NMU) for 1 h. Seedlings were planted out separately and leaves no. 1-6 were scored individually after expansion was...

Cite
Davidson D, Pertens E, Armstrong SW. Changes in frequencies of variegated leaves in NMU treated tobacco : Evidence for a differential response to NMU. Theor Appl Genet. 1987;73(6):915-9doi: 10.1007/BF00289398.
Davidson, D., Pertens, E., & Armstrong, S. W. (1987). Changes in frequencies of variegated leaves in NMU treated tobacco : Evidence for a differential response to NMU. TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik, 73(6), 915-9. https://doi.org/10.1007/BF00289398
Davidson, D, et al. "Changes in frequencies of variegated leaves in NMU treated tobacco : Evidence for a differential response to NMU." TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik vol. 73,6 (1987): 915-9. doi: https://doi.org/10.1007/BF00289398
Davidson D, Pertens E, Armstrong SW. Changes in frequencies of variegated leaves in NMU treated tobacco : Evidence for a differential response to NMU. Theor Appl Genet. 1987 Apr;73(6):915-9. doi: 10.1007/BF00289398. PMID: 24241303.
Copy Download .nbib Format: NLM
Erratum: Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins.

Nature medicine

Lee SC, Dvinge H, Kim E, Cho H, Micol JB, Chung YR, Durham BH, Yoshimi A, Kim YJ, Thomas M, Lobry C, Chen CW, Pastore A, Taylor J, Wang X, Krivtsov A, Armstrong SA, Palacino J, Buonamici S, Smith PG, Bradley RK, Abdel-Wahab O.
PMID: 27270779
Nat Med. 2016 Jun 07;22(6):692. doi: 10.1038/nm0616-692d.

No abstract available.

Cite
Lee SC, Dvinge H, Kim E, et al. Erratum: Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins. Nat Med. 2016;22(6):692doi: 10.1038/nm0616-692d.
Lee, S. C., Dvinge, H., Kim, E., Cho, H., Micol, J. B., Chung, Y. R., Durham, B. H., Yoshimi, A., Kim, Y. J., Thomas, M., Lobry, C., Chen, C. W., Pastore, A., Taylor, J., Wang, X., Krivtsov, A., Armstrong, S. A., Palacino, J., Buonamici, S., Smith, P. G., Bradley, R. K., & Abdel-Wahab, O. (2016). Erratum: Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins. Nature medicine, 22(6), 692. https://doi.org/10.1038/nm0616-692d
Lee, Stanley Chun-Wei, et al. "Erratum: Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins." Nature medicine vol. 22,6 (2016): 692. doi: https://doi.org/10.1038/nm0616-692d
Lee SC, Dvinge H, Kim E, Cho H, Micol JB, Chung YR, Durham BH, Yoshimi A, Kim YJ, Thomas M, Lobry C, Chen CW, Pastore A, Taylor J, Wang X, Krivtsov A, Armstrong SA, Palacino J, Buonamici S, Smith PG, Bradley RK, Abdel-Wahab O. Erratum: Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins. Nat Med. 2016 Jun 07;22(6):692. doi: 10.1038/nm0616-692d. PMID: 27270779; PMCID: PMC6146390.
Copy Download .nbib Format: NLM
Frank COHEN (1879-1960).

American journal of clinical pathology

ARMSTRONG RS.
PMID: 13684318
Am J Clin Pathol. 1960 Nov;34:465. doi: 10.1093/ajcp/34.5.465.

No abstract available.

Cite
ARMSTRONG RS. Frank COHEN (1879-1960). Am J Clin Pathol. 1960;34:465doi: 10.1093/ajcp/34.5.465.
ARMSTRONG, R. S. (1960). Frank COHEN (1879-1960). American journal of clinical pathology, 34465. https://doi.org/10.1093/ajcp/34.5.465
ARMSTRONG, R S. "Frank COHEN (1879-1960)." American journal of clinical pathology vol. 34 (1960): 465. doi: https://doi.org/10.1093/ajcp/34.5.465
ARMSTRONG RS. Frank COHEN (1879-1960). Am J Clin Pathol. 1960 Nov;34:465. doi: 10.1093/ajcp/34.5.465. PMID: 13684318.
Copy Download .nbib Format: NLM
Electrochemical Behavior of the Fe(III) Complexes of the Cyclic Hydroxamate Siderophores Alcaligin and Desferrioxamine E.

Inorganic chemistry

Spasojevic I, Armstrong SK, Brickman TJ, Crumbliss AL.
PMID: 11673947
Inorg Chem. 1999 Feb 08;38(3):449-454. doi: 10.1021/ic980635n.

The redox behavior of Fe(III) complexes of the cyclic hydroxamate siderophores alcaligin and desferrioxamine E was investigated by cyclic voltammetry. The limiting, pH independent redox potential (E(1/2) vs NHE) is -446 mV for alcaligin above pH 9 and -477...

Cite
Spasojevic I, Armstrong SK, Brickman TJ, et al. Electrochemical Behavior of the Fe(III) Complexes of the Cyclic Hydroxamate Siderophores Alcaligin and Desferrioxamine E. Inorg Chem. 1999;38(3):449-454doi: 10.1021/ic980635n.
Spasojevic, I., Armstrong, S. K., Brickman, T. J., & Crumbliss, A. L. (1999). Electrochemical Behavior of the Fe(III) Complexes of the Cyclic Hydroxamate Siderophores Alcaligin and Desferrioxamine E. Inorganic chemistry, 38(3), 449-454. https://doi.org/10.1021/ic980635n
Spasojevic, Ivan, et al. "Electrochemical Behavior of the Fe(III) Complexes of the Cyclic Hydroxamate Siderophores Alcaligin and Desferrioxamine E." Inorganic chemistry vol. 38,3 (1999): 449-454. doi: https://doi.org/10.1021/ic980635n
Spasojevic I, Armstrong SK, Brickman TJ, Crumbliss AL. Electrochemical Behavior of the Fe(III) Complexes of the Cyclic Hydroxamate Siderophores Alcaligin and Desferrioxamine E. Inorg Chem. 1999 Feb 08;38(3):449-454. doi: 10.1021/ic980635n. PMID: 11673947.
Copy Download .nbib Format: NLM
Consultation-Liaison Psychiatry: Drug-Drug Interactions Update.

Psychosomatics

Armstrong SC, Cozza KL.
PMID: 10675391
Psychosomatics. 2000 Feb;41(1):76-77. doi: 10.1016/S0033-3182(00)71181-9.

No abstract available.

Cite
Armstrong SC, Cozza KL. Consultation-Liaison Psychiatry: Drug-Drug Interactions Update. Psychosomatics. 2000;41(1):76-77doi: 10.1016/S0033-3182(00)71181-9.
Armstrong, S. C., & Cozza, K. L. (2000). Consultation-Liaison Psychiatry: Drug-Drug Interactions Update. Psychosomatics, 41(1), 76-77. https://doi.org/10.1016/S0033-3182(00)71181-9
Armstrong, and Cozza. "Consultation-Liaison Psychiatry: Drug-Drug Interactions Update." Psychosomatics vol. 41,1 (2000): 76-77. doi: https://doi.org/10.1016/S0033-3182(00)71181-9
Armstrong SC, Cozza KL. Consultation-Liaison Psychiatry: Drug-Drug Interactions Update. Psychosomatics. 2000 Feb;41(1):76-77. doi: 10.1016/S0033-3182(00)71181-9. PMID: 10675391.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 622 entries